OLYMPIA, Wash.–A Washington bill that would ensure the Medicaid program in the state continues covering HIV antiviral drugs ...

CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

US antivirals giant Gilead Sciences recently announced that the US Food and Drug Administration (FDA) has accepted its New ...

Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication. However, viruses are dynamic ...

Gilead (GILD) stock won an upgrade from Deutsche Bank on HIV treatment boost, while Merck (MRK) stock received a downgrade on Keytruda patent cliff. Read more here.

Lenacapavir is a twice-yearly injectable medication designed to be used as pre-exposure prophylaxis (PrEP). The FDA is giving this drug a priority review and expects to make a decision by June 19, ...

Viruses, like those that cause COVID-19 or HIV, are formidable opponents ... and how to design those drugs. Though we already have antivirals for COVID-19, in a situation like a pandemic, tools ...

Now millions of people take drugs known as antivirals that keep HIV from spreading in the body. Stopping those drugs lets the virus start multiplying in the body again, and it could become drug ...

"We are ecstatic to have W-2 back on our home planet safely and are proud to support significant reentry research for our ...

Twenty million people around the world died before the program was founded. Now millions of people take drugs known as antivirals that keep HIV from spreading in the body. Stopping those drugs lets ...